The global dialysis market is evolving rapidly as the prevalence of chronic kidney disease (CKD), end-stage renal disease (ESRD), diabetes, and hypertension continues to increase worldwide. Advances in hemodialysis and peritoneal dialysis technologies, growing adoption of home-based treatment, digital patient monitoring, and improvements in dialysis equipment and consumables are transforming renal care.

The global hemodialysis and peritoneal dialysis market is projected to grow from USD 102.7 billion in 2026 to USD 141.5 billion by 2031, registering a CAGR of 6.6% during 2026–2031. The market includes hemodialysis equipment, dialysates, peritoneal dialysis machines, consumables, dialysis services, and related technologies. 

North America represented approximately 46.2% of the market in 2025, while ESRD accounted for the largest disease-indication share at 53.5%. Home hemodialysis is projected to be the fastest-growing hemodialysis service segment, with a forecast CAGR of 11.4% through 2031. Automated peritoneal dialysis (APD) held the largest share among PD modalities in 2025. 

Key Trends Shaping the Dialysis Market

Several developments are influencing the competitive landscape through 2031:

• Growth of home dialysis: Healthcare providers and manufacturers are increasingly developing technologies that make dialysis easier to administer outside traditional dialysis centers.

• Digital and connected dialysis: Remote monitoring, cloud-based platforms, connected machines, and therapy-management software are becoming increasingly important.

• Advances in dialysis machines: Manufacturers are improving automation, treatment monitoring, usability, and therapy flexibility.

• Next-generation dialyzers: Improvements in membrane technology, including medium-cut-off membranes, are supporting the development of more advanced dialysis therapies.

• Increasing demand for consumables: Dialyzers, bloodlines, vascular access products, concentrates, fluids, and other consumables remain essential components of dialysis delivery.

• Expansion of peritoneal dialysis: APD and other home-based PD approaches are receiving increasing attention as healthcare systems seek flexible treatment options.

• Integrated care models: Companies are increasingly combining devices, consumables, digital technologies, and dialysis services to provide broader renal-care solutions.

MarketsandMarkets identifies Fresenius Medical Care, Vantive, B. Braun, Nipro Corporation, and Nikkiso among the prominent companies in the global hemodialysis and peritoneal dialysis market. 

Spotlights on Leading Dialysis Companies

1. Fresenius Medical Care AG

Fresenius Medical Care is a major global provider of dialysis products and services, with activities spanning dialysis equipment, dialyzers, consumables, renal pharmaceuticals, and dialysis care delivery. Its integrated presence across products and clinical services gives the company exposure to multiple parts of the dialysis value chain.

The company continues to develop dialysis technologies and care models across in-center and home-based treatment. MarketsandMarkets identifies Fresenius Medical Care as one of the prominent players in the global hemodialysis and peritoneal dialysis market. 

2. DaVita Inc.

DaVita is a major dialysis service provider with a substantial presence in outpatient dialysis care. Its operations focus heavily on delivering kidney-care services to patients requiring chronic dialysis.

The company’s position within the dialysis services ecosystem provides exposure to trends such as value-based kidney care, home dialysis, patient engagement, and technology-enabled treatment management.

3. Vantive

Vantive operates as an independent kidney-care company following its separation from Baxter’s kidney-care business in 2025. The company focuses on kidney-care technologies spanning peritoneal dialysis, hemodialysis, continuous renal replacement therapy, and related digital solutions.

Its portfolio includes home dialysis technologies and digitally enabled therapy-management capabilities. MarketsandMarkets identifies Vantive among the leading companies in the global hemodialysis and peritoneal dialysis market. 

4. U.S. Renal Care, Inc.

U.S. Renal Care is a US-based kidney-care provider with a focus on dialysis services. The company supports patients through in-center and home dialysis programs.

The increasing emphasis on home-based kidney care creates opportunities for dialysis providers to expand remote monitoring, patient education, therapy support, and digitally enabled care models.

5. B. Braun SE

B. Braun is a global medical technology company with an extensive dialysis portfolio through its Avitum business. Its offerings include dialysis machines, dialyzers, bloodlines, concentrates, water-treatment systems, and other dialysis products.

B. Braun also operates dialysis centers in multiple international markets. Its broad product portfolio allows it to participate across several stages of dialysis treatment and infrastructure. 

6. Nipro Corporation

Nipro is a Japanese healthcare company with a significant presence in dialysis products and technologies. Its portfolio includes dialyzers, dialysis machines, blood tubing sets, vascular access needles, peritoneal dialysis products, and related technologies.

The company’s hollow-fiber membrane technology and broad dialysis product portfolio support its position across the global dialysis equipment and consumables market. 

7. Diaverum AB

Diaverum is an international renal-care provider focused on dialysis and kidney-care services. Its operations include dialysis clinics and patient-centered renal-care programs across multiple markets.

The company participates primarily on the service side of the dialysis ecosystem, where increasing patient volumes and demand for specialized kidney care are supporting market development.

8. Asahi Kasei Medical Co., Ltd.

Asahi Kasei Medical develops medical technologies and products used in renal care, including dialysis-related technologies and blood purification solutions.

Its expertise in membrane technologies and medical materials supports the broader development of advanced extracorporeal treatment solutions.

9. Toray Industries, Inc.

Toray Industries is a diversified Japanese technology company with significant expertise in advanced materials and healthcare technologies. Through its medical business, the company participates in dialysis and blood purification technologies.

Toray’s expertise in membrane materials is particularly relevant to the development of dialyzers and other filtration-based medical technologies.

10. Nikkiso Co., Ltd.

Nikkiso is a Japanese manufacturer with a strong presence in dialysis equipment and related medical technologies. Its dialysis portfolio includes the DBB series of dialysis machines supporting different treatment modalities.

MarketsandMarkets identifies Nikkiso as one of the prominent players in the global dialysis market. The company has also expanded its international presence beyond Japan. 

11. Mozarc Medical

Mozarc Medical focuses on kidney-care technologies and solutions designed to support patients and healthcare professionals across the renal-care journey.

Its portfolio and development activities are aligned with the broader industry movement toward patient-centered treatment, home dialysis, and technologies designed to improve the dialysis experience.

12. BD

Becton, Dickinson and Company (BD) is a global medical technology company with products and technologies used across healthcare delivery. Its relevance to dialysis includes vascular access and other technologies supporting clinical procedures and renal-care workflows.

BD’s broad healthcare portfolio allows it to participate in supporting infrastructure around dialysis treatment.

13. JMS Co., Ltd.

JMS is a Japanese medical-device manufacturer providing products across infusion, blood-management, and dialysis-related applications.

Its dialysis portfolio includes products used in extracorporeal treatment workflows. The company serves healthcare markets internationally and contributes to the consumables segment of the dialysis ecosystem.

14. Merit Medical Systems

Merit Medical Systems develops and manufactures medical devices used in interventional, diagnostic, and therapeutic procedures.

Within the broader renal-care ecosystem, the company’s technologies are relevant to vascular access and procedural applications associated with dialysis patients.

15. Terumo Corporation

Terumo is a global medical technology company with products spanning cardiovascular care, blood management, hospital systems, and other medical applications.

Its expertise in blood-management technologies and medical devices gives it relevance to the broader dialysis and extracorporeal-treatment ecosystem.

16. Allmed Medical Products Co., Ltd.

Allmed Medical Products is involved in the development and manufacture of dialysis-related medical products and consumables.

Its portfolio supports dialysis treatment workflows, particularly in areas such as dialyzers and related disposable products. Growing global demand for dialysis consumables provides opportunities for manufacturers serving this segment.

17. Outset Medical, Inc.

Outset Medical focuses on dialysis technology, particularly systems designed to simplify hemodialysis delivery. Its Tablo Hemodialysis System is designed to support dialysis treatment in healthcare facilities and home settings.

The company’s focus aligns with the broader movement toward simpler, more flexible dialysis delivery and expansion of home-based treatment. MarketsandMarkets identifies Outset Medical among emerging companies in the dialysis market. 

18. Rockwell Medical, Inc.

Rockwell Medical develops products used in dialysis treatment, with a particular focus on dialysis concentrates and related renal-care products.

Its specialization positions the company within the dialysis consumables segment, which remains an important part of the overall dialysis market.

MarketsandMarkets identifies Rockwell Medical among emerging players in the market, particularly within the evolving landscape of specialized dialysis technologies and products. 

19. AmeriWater LLC

AmeriWater provides water-treatment and water-purification technologies for healthcare applications, including dialysis facilities.

High-quality water is an essential component of dialysis treatment, making water-treatment systems an important supporting technology within the dialysis infrastructure. Increasing investment in dialysis facilities creates opportunities for specialized water-treatment suppliers.

20. Dialife SA

Dialife is a healthcare technology company associated with dialysis products and renal-care technologies.

The company participates in the broader dialysis equipment and consumables ecosystem, supporting healthcare providers seeking reliable technologies for dialysis treatment.

21. Quanta Dialysis Technologies Ltd

Quanta Dialysis Technologies develops dialysis systems designed to provide flexible and simplified hemodialysis treatment.

The company’s technology focus is closely aligned with the industry’s transition toward more accessible and potentially decentralized dialysis delivery. Home dialysis and treatment flexibility remain important areas of market development through 2031.

22. Isopure Corp.

Isopure participates in the dialysis ecosystem through technologies and products associated with dialysis water and related treatment requirements.

As dialysis providers increasingly focus on treatment quality, facility infrastructure, and operational efficiency, supporting technologies such as water purification remain essential to dialysis delivery.

23. Poly Medicure Limited

Poly Medicure is an Indian medical-device manufacturer with a broad portfolio of disposable medical products, including products used in dialysis and extracorporeal treatment.

Its manufacturing capabilities and international presence position it within the growing medical consumables segment. Expansion of healthcare infrastructure in emerging markets may create additional opportunities for dialysis-product manufacturers.

24. Atlantic Biomedical

Atlantic Biomedical participates in the medical-device sector and contributes products and technologies relevant to healthcare treatment environments.

Companies operating in specialized medical-device segments can benefit from the expanding demand for dialysis infrastructure, equipment, and supporting products as the global renal-care burden increases.

25. Amecath

Amecath is a medical-device manufacturer with products spanning several healthcare applications, including dialysis-related products.

Its participation in the dialysis ecosystem reflects the growing role of specialized manufacturers supplying consumables and supporting technologies to renal-care providers.